TrialHaematologica2015

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival.

Henk M Lokhorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.